Keywords: Roche, Genentech, Constellation Pharma, Epigenetics, Cancer, Acquisition option

Roche in epigenetics drug discovery collaboration

Article | 18 January 2012

Print This

USA-based Constellation Pharmaceuticals says that it has entered into a major strategic agreement with Genentech, a subsidiary of Swiss drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in